Advertisement
Screener

INNOVATION PHARMACEUTICALS INC. Financing Cash Flow

INNOVATION PHARMACEUTICALS INC. Financing Cash Flow

INNOVATION PHARMACEUTICALS INC. reported Financing Cash Flow of $25.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-11-20

  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $25.00K.
  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was -$41.00K.
  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $3.00K.
  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was -$41.00K, a 104.14% decline year-over-year.
  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2023 was -$123.00K, a 103.10% decline from fiscal 2022.
  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2022 was $3.97M, a 71.09% decline from fiscal 2021.
  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2021 was $13.74M, a 41.89% increase from fiscal 2020.
  • INNOVATION PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2020 was $9.69M, a 113.68% increase from fiscal 2019.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 51 monthNet Cash Provided by (Used in) Financing Activities 54 monthNet Cash Provided by (Used in) Financing Activities 57 monthNet Cash Provided by (Used in) Financing Activities 60 monthNet Cash Provided by (Used in) Financing Activities 63 month
2023-09-30$25.00K
10-Q · filed 2023-11-20
-$16.00K
derived: sum of 2 quarters · filed 2023-11-20
-$13.00K
derived: sum of 3 quarters · filed 2023-11-20
-$54.00K
derived: sum of 4 quarters · filed 2023-11-20
2023-06-30-$41.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
-$38.00K
derived: sum of 2 quarters · filed 2023-09-28
-$79.00K
derived: sum of 3 quarters · filed 2023-09-28
-$123.00K
10-K · filed 2023-09-28
2023-03-31$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15
-$38.00K
derived: sum of 2 quarters · filed 2023-05-15
-$82.00K
10-Q · filed 2023-05-15
-$82.00K
derived: sum of 4 quarters · filed 2023-11-20
2022-12-31-$41.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-15
-$85.00K
10-Q · filed 2023-02-15
-$85.00K
derived: sum of 3 quarters · filed 2023-11-20
-$85.00K
derived: sum of 4 quarters · filed 2023-11-20
2022-09-30-$44.00K
10-Q · filed 2023-11-20
-$44.00K
derived: sum of 2 quarters · filed 2023-11-20
-$44.00K
derived: sum of 3 quarters · filed 2023-11-20
$946.00K
derived: sum of 4 quarters · filed 2023-11-20
2022-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
$0.00
derived: sum of 2 quarters · filed 2023-09-28
$990.00K
derived: sum of 3 quarters · filed 2023-09-28
$3.97M
10-K · filed 2023-09-28
2022-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15
$990.00K
derived: sum of 2 quarters · filed 2023-05-15
$3.97M
10-Q · filed 2023-05-15
$3.78M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$990.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-15
$3.97M
10-Q · filed 2023-02-15
$3.78M
derived: sum of 3 quarters · filed 2023-02-15
$10.79M
derived: sum of 4 quarters · filed 2023-02-15
2021-09-30$2.98M
10-Q · filed 2022-11-10
$2.79M
derived: sum of 2 quarters · filed 2022-11-10
$9.80M
derived: sum of 3 quarters · filed 2022-11-10
$13.97M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$197.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28
$6.82M
derived: sum of 2 quarters · filed 2022-09-28
$10.98M
derived: sum of 3 quarters · filed 2022-09-28
$13.74M
10-K · filed 2022-09-28
2021-03-31$7.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13
$11.18M
derived: sum of 2 quarters · filed 2022-05-13
$13.94M
10-Q · filed 2022-05-13
$21.04M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$4.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14
$6.92M
10-Q · filed 2022-02-14
$14.02M
derived: sum of 3 quarters · filed 2022-02-14
$15.51M
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30$2.76M
10-Q · filed 2021-11-09
$9.86M
derived: sum of 2 quarters · filed 2021-11-09
$11.35M
derived: sum of 3 quarters · filed 2021-11-09
$11.47M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$7.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27
$8.59M
derived: sum of 2 quarters · filed 2021-09-27
$8.71M
derived: sum of 3 quarters · filed 2021-09-27
$9.69M
10-K · filed 2021-09-27
2020-03-31$1.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13
$1.61M
derived: sum of 2 quarters · filed 2021-05-13
$2.59M
10-Q · filed 2021-05-13
$4.07M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$125.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-22
$1.10M
10-Q · filed 2021-02-22
$2.58M
derived: sum of 3 quarters · filed 2021-02-22
$3.34M
derived: sum of 4 quarters · filed 2021-02-22
2019-09-30$972.00K
10-Q · filed 2020-11-16
$2.45M
derived: sum of 2 quarters · filed 2020-11-16
$3.21M
derived: sum of 3 quarters · filed 2020-11-16
2019-06-30$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-14
$2.24M
derived: sum of 2 quarters · filed 2020-09-14
$4.53M
10-K · filed 2020-09-14
2019-03-31$761.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14
$3.05M
10-Q · filed 2020-05-14
2018-12-31$2.29M
10-Q · filed 2020-02-13
2018-06-30$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30
$5.36M
derived: sum of 2 quarters · filed 2019-09-30
$9.16M
derived: sum of 3 quarters · filed 2019-09-30
$11.66M
10-K · filed 2019-09-30
2018-03-31$1.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10
$5.16M
derived: sum of 2 quarters · filed 2019-05-10
$7.67M
10-Q · filed 2019-05-10
2017-12-31$3.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-08
$6.31M
10-Q · filed 2019-02-08
2017-09-30$2.50M
10-Q · filed 2018-11-08
2017-06-30$9.88M
10-K · filed 2018-09-11
2012-09-30$350.00K
10-Q · filed 2012-11-19
$450.00K
derived: sum of 2 quarters · filed 2012-11-19
-$17.10K
derived: sum of 3 quarters · filed 2012-11-19
$982.90K
derived: sum of 4 quarters · filed 2012-11-19
$3.21M
10-Q · filed 2012-11-19
2012-06-30$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-12
-$367.10K
derived: sum of 2 quarters · filed 2012-10-12
$632.90K
derived: sum of 3 quarters · filed 2012-10-12
$652.90K
10-K · filed 2012-10-12
$2.86M
10-K · filed 2012-10-12
2012-03-31-$467.10K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-18
$532.90K
derived: sum of 2 quarters · filed 2012-05-18
$552.90K
10-Q · filed 2012-05-18
$702.90K
derived: sum of 4 quarters · filed 2012-11-19
$2.76M
10-Q · filed 2012-05-18
2011-12-31$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14
$1.02M
10-Q · filed 2012-02-14
$1.17M
derived: sum of 3 quarters · filed 2012-11-19
$1.25M
derived: sum of 4 quarters · filed 2012-11-19
$3.23M
10-Q · filed 2012-02-14
2011-09-30$20.00K
10-Q · filed 2012-11-19
$170.00K
derived: sum of 2 quarters · filed 2012-11-19
$250.00K
derived: sum of 3 quarters · filed 2012-11-19
$300.37K
derived: sum of 4 quarters · filed 2012-11-19
$2.23M
10-Q · filed 2011-11-21
2011-06-30$150.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-12
$230.00K
derived: sum of 2 quarters · filed 2012-10-12
$280.37K
derived: sum of 3 quarters · filed 2012-10-12
$800.37K
10-K · filed 2012-10-12
2011-03-31$80.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-18
$130.37K
derived: sum of 2 quarters · filed 2012-05-18
$650.37K
10-Q · filed 2012-05-18
2010-12-31$50.37K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14
$570.37K
10-Q · filed 2012-02-14
2010-09-30$520.00K
10-Q · filed 2011-11-21